生理学指导的完全血运重建在老年心梗患者衰弱谱系中获益一致:FIRE试验预设分析
该预设分析基于FIRE试验中1445例≥75岁多支病变心梗患者,按临床衰弱量表(CFS)分层分析1010例。结果显示衰弱程度越高主要终点风险越高(HR 1.62,95%CI 1.19-2.20;
要点
- 完全血运重建降低主要终点,与CFS分层无显著交互作用(交互P=0.769)。
- 完全血运重建的获益在CFS全评分范围内保持一致。
核心结论
- CFS评估的衰弱与老年心梗患者不良结局独立相关。
- 完全血运重建无论衰弱状态如何均有效,应考虑用于所有接受侵入性策略的老年多支病变心梗患者。
研究设计与样本
- FIRE试验的预设分析,1445例≥75岁心梗合并多支病变患者随机接受完全或仅罪犯血管血运重建。
- 1010例(70%)按CFS分层:1-3分非衰弱,4分衰弱前期,5-9分衰弱。
- 主要终点为3年死亡、心梗、卒中或缺血驱动血运重建的复合终点。
主要发现
- 分层队列中非衰弱523例(52%)、衰弱前期304例(30%)、衰弱183例(18%)。
- 完全血运重建降低主要终点,血运重建策略与CFS分类无显著交互作用(交互P=0.769)。
- 完全血运重建的获益在CFS全评分范围内保持一致,次要终点结果相似,安全性结局无显著交互作用。
关键数值与推荐
- CFS评分1-3分为非衰弱,4分为衰弱前期,5-9分为衰弱。
- 主要终点3年复合终点包括死亡、心梗、卒中或缺血驱动血运重建。
- 完全血运重建对比仅罪犯血管血运重建的主要终点获益在各CFS分层间无显著交互作用(交互P=0.769)。
临床怎么用
- 对≥75岁多支病变心梗患者,评估CFS以识别衰弱高风险人群。
- 不应仅因衰弱而否决完全血运重建,接受侵入性策略者均可考虑完全血运重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The number of older patients admitted with myocardial infarction (MI) is increasing, and their clinical profiles range from very fit to frail and functionally impaired. OBJECTIVES: To evaluate whether the benefits of complete revascularization are consistent across subpopulations of older MI patients stratified by the Clinical Frailty Scale (CFS). METHODS: In the FIRE trial, 1445 patients aged ≥75 years with MI and multivessel disease were randomized to either complete or culprit-only revascularization. Overall, 1010 patients (70%) were stratified according to CFS (scores 1-3 non-frail, 4 pre-frail, 5-9 frail). The primary endpoint was a 3-year composite of death, MI, stroke, or ischemia-driven revascularization. RESULTS: Of the stratified cohort, 523 (52%) were non-frail, 304 (30%) pre-frail, and 183 (18%) frail. Increasing frailty was significantly associated with a higher risk of the primary endpoint (HR 1.62, 95% CI 1.19-2.20; P = .002). Complete revascularization reduced the primary endpoint with no significant interaction between revascularization strategy and CFS category (p for interaction = 0.769). The benefit of complete versus culprit-only revascularization remained consistent across the full range of CFS scores. Similar findings were observed for secondary endpoints, and no significant interaction emerged for safety outcomes. CONCLUSIONS: Frailty, as assessed by the CFS, was independently associated with adverse outcomes. Complete revascularization was effective regardless of frailty status and should be considered in all older MI patients with multivessel disease undergoing an invasive strategy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03772743.
引用
- Passo BD, Tonet E, Lanzilotti V, et al. Consistent benefit of physiology-guided complete revascularization across the spectrum of frailty in older patients with myocardial infarction: a prespecified analysis of the FIRE trial. Age Ageing. 2026. PMID: 41965249. doi:10.1093/ageing/afag078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。